ABSTRACT
INTRODUCTION
Thioacetamide is a potent selective hepatotoxin, which has been widely used to induce acute and chronic liver injury (1) . Oxidative injury has been recognized as the major mechanism in thioacetamide induced liver damage, the oxidative metabolism of thioacetamide through the hepatic FAD monooxygenase system and cytochrome P-450 monooxygenase system produces reactive oxidative agents especially the very reactive compound. Thioacetamide-S-dioxide targets tissue macromolecules lipids, protein, and DNA-leading to tissue oxidative injury and necrosis It has been observed that thioacetamide causes tissue injury and necrosis/apoptosis through several processes related to lipid, protein and DNA peroxidation (2) . Zinc is an essential element for all living organism (3) . During the course of evolution, all organisms have taken up compound available from their environment and used for specific functions of their metabolism. Hence, organisms have developed a mechanism that allows them to regulate zinc uptake.
During the International Conference on Zinc and Human Health, (2000) held in Stockholm, researchers and nutritionists discussed the determination of zinc requirements, the assessment of zinc status at individual and population levels, and the risks linked to zinc deficiency.
The conclusions of the conference provided evidence of the importance of zinc in human health (4) . Zinc is essential for the normal growth and reproduction of all higher plants, animals, and humans, and it is therefore called a ‫״‬micronutrient. Zinc has never been shown to interact directly with oxidant substances, but it exerts a protective antioxidant effect indirectly (5) . Some possible antioxidant actions of zinc are (i)protective effect against vitamin E depletion, (ii) stabilization ofmembrane structure, (iii) limitation of endogenous free radical production, (iv) contribution to the structure of extracellular superoxide dismutase. Zinc plays an important role in protecting DNA from damage as a component of many DNA repair proteins (6) .
MATERIALS & METHODS
White male albino rats (Rattus norvegicus) weighing about 200 ± 40 g. were used as experimental animals in the present investigation. They were obtained from the animal house of Research Institute of Ophthalmology, El-Giza, Egypt and were kept under observation for about 15 days before the onset of the experiment to exclude any intercurrent infection. The chosen animals were housed in stainless steel cages at normal atmospheric temperature (25± 5°C) and had a 12 h light -dark cycle (light on at 6.00 -18. 00h). Food and water were consumed ad libitum.
Thioacetamide:
Thioacetamide was used as an inducer for liver cirrhosis. It was purchased from Sigma company (United Kingdom).
Induction of liver cirrhosis by thioacetamide:
A single injection (400 mg/kg b.wt. of TAA, dissolved in normal saline) was given intraperitoneally.
Zinc acetate and its dose:
Zinc acetate was purchased from Sigma company (United Kingdom).
Zinc acetate dose:
10 mg Zn/kg body weight of zinc acetate given by oral gaveage daily for all experimental period (7) . Animal grouping Group I (n=10) normal control group was given distilled water orally and daily administered for 4 weeks. Group II (n=10) TAA induced control group was given thioacetamide intraperitoneally injection 400 mg/kg b.wt. of rat. Group III (n=10) rats given intraperitoneally injection of thioacetamide 400 mg/kg b.wt. of rat then given by oral gaveage 10 mg/kg b.wt. of rat of zinc acetate for 4 weeks. Group IV (n=10) rats given orally zinc acetate 10 mg/kg b.wt. of rats for one week then given intraperitoneally injection then complete oral gaveage zinc acetate 10 mg/kg b.wt. of rat for 4 weeks Biochemical Investigations:
By the end of the experimental periods (4 weeks), rats were scarified under diethyl ether anesthesia at fasting state. The portion of blood samples were collected and allowed to coagulate at room temperature; other portion of blood added to it, EDTA (ethylene diamine tetracetic acid) and centrifuged at 3000 r.p.m. for 30 minutes. The clear, non-haemolysed supernatant sera and plasma were quickly removed divided into four portions for each individual, and stored at -20°C for subsequent analysis.
Serum ALT and AST activities in serum was determined according to the method of Reitman and Frankel (8) using reagent kits purchased from BioMerieux Chemical Company (France). Plasma total bilirubin and direct bilirubin concentrations were determined according to the method of Jendrassik (9) using the reagent kits purchased from Diamond Diagnostics (Egypt). The content of reduced GSH was determined by modifying the method of Jollow et al.
(10) . SOD activity was assayed as described by Kar and Mishra(11). Catalase activity was assayed as described by Choen et al.
(12) . A modification of the thiobarituric acid method was employed for the estimation of malondialdehyde according to Wright et al.
(13) . Brifely, after incubation for 60 min at 37ºc , a 1.0 ml aliquot of the liver homogenate was mixed with 1.0 ml 40% trichloroacetic acid (TCA), followed by addition of 1.0 ml 2%thiobarbituric acid. The mixture was boiled for 15 min,cooled in an ice bath for 5 min, and than 1 ml 40%TCA was added to it .After standing for 20 min, the mixture was centrifuged at 800 g. for 20 min, and the absorbence of the supernatant read at 532nm. The cirrhotic rats exhibited a very highly significant increase (P<0.001) of serum ALT and AST activity as compared to the normal rats. The oral treatment of cirrhotic rats with zinc acetate exerted a very highly significant decrease (P<0.001) in serum ALT and AST activity as compared to the cirrhotic rats. The TAA. induced rats showed a very highly significant increase in plasma bilirubin level as compared to normal control rat group. The oral treatment of cirrhotic rats with zinc acetate exerted a very highly significant decrease (P< 0.001) in plasma bilirubin as compared to the cirrhotic rats. The cirrhotic rats exhibited a very highly significant decrease (P<0.001) of hepatic GSH level as compared to the normal rats. The oral treatment of cirrhotic rats with zinc acetate to TAA. induction exerted a very highly significant (P<0.001) increase as compared to cirrhotic control group.
RESULTS
On the other hand, the hepatic MDA level showed a very highly significant increase (P<0.001) as compared to the normal rats. The oral administration of zinc acetate produced marked improvement (P< 0.001) of the altered hepatic MDA level of the cirrhotic rats. The cirrhotic rats exhibited a very highly significant decrease (P<0.001) of hepatic catalase activity as compared to the normal rats. The oral treatment of cirrhotic rats with zinc acetate exerted a significant increase (P<0.05) in hepatic catalase activity as compared to the cirrhotic rats. While, the protective groups showed a highly significant (P<0.01) increase as compared to cirrhotic control group.Olso, the hepatic SOD activity showed a very highly significant decrease (P<0.001) as compared to the normal rats. The oral administration of zinc acetate produced improvement of the altered hepatic SOD activity of the cirrhotic rats.
DISCUSSION
Oxidative stress has been implicated in liver cirrhosis. Carbon tetrachloride and thioacetamide are the most widely used models to develop cirrhosis in rats (14) . whom showed the influence of zinc sulfate intake on acute ethanol-induced liver injury in rats.
The treatment with zinc acetate reversed the hyperbililirubinemia effect of thioacetamide on albino rats.
The role of Zn in the protection from free radical damage may take several forms, through maintaining an adequate level of metallothionein, an essential component of Cu, Zn-SOD, a protective agent for thiols and other chemical groups (28) , that appear in the reduction of MDA level and increase in the activities of catalase and SOD after treatment with zinc acetate.
In conclusion, biochemical evaluations revealed that zinc acetate has a protective effect on thioacetamide induced liver injury. In such results zinc could acts as an antioxidant agent in hepatic antioxidant systems after thioacetamide administration. In addition, Zinc may be a therapeutic agent in the prevention and treatment of thioacetamide induced liver injury.
